Refractory, primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Also known as: Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB05015 | Belinostat | 1 | Recruiting | 1 |
| DB08870 | Brentuximab vedotin | 1 | Withdrawn | 1 |
| DB08889 | Carfilzomib | 1 | Recruiting | 1 |
| DB09331 | Daratumumab | 1 | Recruiting | 1 |
| DB09502 | Fludeoxyglucose F-18 | 1 | Recruiting | 1 |
| DB00441 | Gemcitabine | 1 | Recruiting | 1 |
| DB00480 | Lenalidomide | 1 | Withdrawn | 1 |
| DB09035 | Nivolumab | 1 | Recruiting | 1 |
| DB08935 | Obinutuzumab | 1 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
| DB00073 | Rituximab | 1 | Recruiting | 1 |
| DB06176 | Romidepsin | 1 | Active Not Recruiting | 1 |
| DB06176 | Romidepsin | 1 | Recruiting | 1 |
| DB00072 | Trastuzumab | 1 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Recruiting | 1 |
| DB06176 | Romidepsin | 1 / 2 | Recruiting | 1 |
| DB08870 | Brentuximab vedotin | 2 | Recruiting | 1 |
| DB00480 | Lenalidomide | 2 | Recruiting | 1 |
| DB06132 | Nivolumab | 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |
| DB13896 | Talimogene laherparepvec | 2 | Recruiting | 1 |